Y-mabs therapeutics inc.

Major-Pharmaceuticals

YMAB


230 Park Avenue
New York , NY 10169

Executive/
Director

Price

  • Last Close
  • $ 8.16
    $ +0.19 2.45 %
    Jan 3, 2025
  • 52-Week High/Low
  • $18.69 - $4.86
  • YTD
  • 4.2%

  • Trading Volume
  • 3,374
  • Market Cap Full
  • $ 356M
  • Shares Outstanding
  • 43.6M
    Nov 6, 2023
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Q1 - - - 28.9% -5% -38.9% -26.7% 2.7% 139% 4.2%
Q2 - - - -18.2% 4% 11.8% 27.4% 35.5% -6.8% -
Q3 - - 10.7% 13% 8% -15.6% -4.7% -19.7% 13.9% -
Q4 - - -21.9% 21.2% 29% -43.2% -66.2% 27.5% -49.7% -
J F M A M J J A S O N D
2025 4.2% - - - - - - - - - - -
2024 87.5% 30.6% -2.4% -7.1% - - - 13.9% - - - -34.4%
    2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
    0%0%0%0%54%58%-67%-70%40%15%4%

Earnings

2016 2017 2018 2019 2020 2021 2022 2023
Q1 - - -0.28 -0.47 -0.66 0.75 -0.64 -0.15
Q2 - - -0.39 -0.53 -1.01 -0.53 -0.94 -0.14
Q3 - - -0.42 -0.7 -0.82 -0.66 -0.63 -0.18
Q4 - - - -0.6 -0.48 -0.84 0.02 -
A 0 0 -1.1 -2.3 -3 -1.3 -2.2 -0.47

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2018 2019 2020 2021 2022 2023
Mar - 34.2 39.8 43.5 43.7 43.7
Jun - 34.2 39.8 43.6 43.7 43.7
Sep - 34.2 40 0 43.7 43.6
Dec 34.2 39.7 40.5 43.6 43.7 43.6

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover 1 0.3 - - -
Fixed Asset Turnover 9.3 7 4.2 - -
Total Asset Turnover 0.5 0.2 0.2 - -
Leverage
Debt Ratio - - - - -
Debt – Equity Ratio - - - - -
Interest Coverage -95 1.9 120 41.5 -
Equity multiplier 0.1 - 0.1 - -